Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-05 Sale |
2025-02-05 9:04 pm |
Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Operating Officer |
56,537 | $0.78 | $44,099 | 741,439 (Direct) |
View |
| 2025-02-05 Sale |
2025-02-05 8:52 pm |
Spero Therapeutics Inc. | SPRO | Rajavelu Esther CFO & CBO |
20,689 | $0.78 | $16,137 | 724,720 (Direct) |
View |
| 2025-02-05 Sale |
2025-02-05 8:31 pm |
Spero Therapeutics Inc. | SPRO | Shukla Sath CEO & President |
155,333 | $0.78 | $121,160 | 1,736,883 (Direct) |
View |
| 2025-02-05 Sale |
2025-02-05 8:30 pm |
Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director |
69,219 | $0.78 | $53,991 | 689,866 (Direct) |
View |
| 2024-11-07 Sale |
2024-11-12 4:05 pm |
Spero Therapeutics Inc. | SPRO | Rajavelu Esther CFO & CBO |
40,596 | $1.3058 | $53,008 | 379,270 (Direct) |
View |
| 2024-08-27 Sale |
2024-08-29 6:43 pm |
Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director |
5,912 | $1.35 | $7,981 | 759,085 (Direct) |
View |
| 2024-08-27 Sale |
2024-08-29 6:42 pm |
Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Operating Officer |
2,213 | $1.35 | $2,988 | 531,837 (Direct) |
View |
| 2024-08-27 Sale |
2024-08-29 6:36 pm |
Spero Therapeutics Inc. | SPRO | Shukla Sath CEO & President |
2,757 | $1.35 | $3,722 | 1,140,809 (Direct) |
View |
| 2024-08-02 Sale |
2024-08-06 7:56 pm |
Spero Therapeutics Inc. | SPRO | Shukla Sath CEO and President |
32,441 | $1.3146 | $42,646 | 1,143,566 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 8:53 pm |
Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Operating Officer |
30,971 | $1.36 | $42,121 | 534,050 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 8:50 pm |
Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director |
63,795 | $1.37 | $87,399 | 744,997 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 8:48 pm |
Spero Therapeutics Inc. | SPRO | JOSEPH TAMARA L Chief Legal Officer |
30,906 | $1.37 | $42,341 | 531,615 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 8:45 pm |
Spero Therapeutics Inc. | SPRO | HAMED KAMAL Chief Medical Officer |
28,075 | $1.37 | $38,463 | 788,117 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 8:40 pm |
Spero Therapeutics Inc. | SPRO | Shukla Sath CEO and President |
75,994 | $1.4175 | $107,719 | 1,176,007 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-15 5:47 pm |
Spero Therapeutics Inc. | SPRO | HAMED KAMAL Chief Medical Officer |
39,496 | $1.27 | $50,160 | 576,461 (Direct) |
View |
| 2023-08-28 Sale |
2023-08-30 4:23 pm |
Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Development Officer |
1,854 | $1.26 | $2,336 | 325,290 (Direct) |
View |
| 2023-08-28 Sale |
2023-08-30 4:22 pm |
Spero Therapeutics Inc. | SPRO | JOSEPH TAMARA L Chief Legal Officer |
1,854 | $1.26 | $2,336 | 322,790 (Direct) |
View |
| 2023-08-28 Sale |
2023-08-30 4:21 pm |
Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director |
9,040 | $1.26 | $11,390 | 788,792 (Direct) |
View |
| 2023-08-28 Sale |
2023-08-30 4:20 pm |
Spero Therapeutics Inc. | SPRO | Shukla Sath CEO and President |
6,017 | $1.2877 | $7,748 | 572,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-05 9:04 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Operating Officer |
266,139 | $0 | 741,439 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 8:52 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Rajavelu Esther CFO & CBO |
366,139 | $0 | 724,720 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 8:31 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Shukla Sath CEO & President |
751,407 | $0 | 1,736,883 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 4:29 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Deshpande Milind Director |
20,000 | $0 | 71,454 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 4:27 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director |
20,000 | $0 | 55,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 4:25 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director |
20,000 | $0 | 764,997 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 4:25 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director |
20,000 | $0 | 55,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 4:25 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Tregoning Kathleen Director |
20,000 | $0 | 55,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 4:17 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Smith Cynthia Director |
20,000 | $0 | 55,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 4:15 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
20,000 | $0 | 55,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 4:15 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Pottage John C Jr Director |
20,000 | $0 | 55,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 8:53 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Operating Officer |
239,731 | $0 | 534,050 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 8:48 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | JOSEPH TAMARA L Chief Legal Officer |
239,731 | $0 | 531,615 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 8:45 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | HAMED KAMAL Chief Medical Officer |
239,731 | $0 | 788,117 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 8:44 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Rajavelu Esther See Remarks |
119,866 | $0 | 419,866 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 8:40 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Shukla Sath CEO and President |
679,501 | $0 | 1,176,007 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:40 pm |
N/A 2034-01-02 |
Spero Therapeutics Inc. | SPRO | Tregoning Kathleen Director |
35,604 | $1.12 | 35,604 (Direct) |
View |
| 2023-11-13 Option Award |
2023-11-15 4:17 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Rajavelu Esther See Remarks |
300,000 | $0 | 300,000 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 5:43 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Pottage John C Jr Director |
20,000 | $0 | 35,000 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 5:40 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Smith Cynthia Director |
20,000 | $0 | 35,000 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 5:39 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
20,000 | $0 | 35,000 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 5:34 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Deshpande Milind Director |
20,000 | $0 | 51,454 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 5:29 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Tregoning Kathleen Director |
20,000 | $0 | 35,000 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 5:28 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director |
20,000 | $0 | 35,000 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 5:19 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director |
20,000 | $0 | 35,000 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 5:18 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director |
20,000 | $0 | 808,792 (Direct) |
View |
| 2023-08-01 Option Award |
2023-08-03 4:10 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Shukla Sath CEO and President |
266,000 | $0 | 578,517 (Direct) |
View |